SCHEMBL24676467

SCHEMBL24676467

CC1CC(Nc2ncc(F)c(-c3sc(COS(C)(=O)=O)nc3C(F)(F)F)n2)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 9/20 0.36
CDK2 P24941 9/20 0.36
CDK1 P06493 5/20 0.36
CCNB1 P14635 5/20 0.36
CCNB2 O95067 1/20 0.36
CCNE2 O96020 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
GPR119 Q8TDV5 6/20 0.34
CDK4 P11802 5/20 0.34
CCND1 P24385 5/20 0.34
CCND3 P30281 5/20 0.34
CDK6 Q00534 5/20 0.34
MAPK1 P28482 1/20 0.34
DYRK2 Q92630 3/20 0.34
CCNT1 O60563 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33
CCNH P51946 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24676828 0.90 MAPK1 (0.36) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL24676477 0.89 MAPK1 (0.36) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL29754987 0.89 MAPK1 (0.36) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL24676928 0.88 CDK4 (0.36) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL29754914 0.88 CDK4 (0.36) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL24676994 0.83 CDK2 (0.53) CCNE1CDK2CDK1CCNB1CCNB2
SCHEMBL24676598 0.78 DYRK2 (0.44) CDK2CDK1GPR119CDK4CCND1
SCHEMBL24676591 0.78 DYRK2 (0.41) CDK2CDK1GPR119CDK4CCND1
SCHEMBL24676593 0.77 DYRK2 (0.43) CDK2CDK1GPR119CDK4CCND1
SCHEMBL24675994 0.76 CDK2 (0.41) CCNE1CDK2CDK1CCNB1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed